Non-Viral Systems Based on PAMAM-Calix-Dendrimers for Regulatory siRNA Delivery into Cancer Cells

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Molecular Biology

Background:

• Cancer is a leading cause of death in developed nations.
• Gene therapy, particularly RNA interference, shows promise for cancer treatment.
• Effective delivery vectors are crucial for nucleic acid-based therapies, driving research into novel nanomaterials.

Purpose of the Study:

• To investigate the potential of symmetrical polyamidoamine dendronized thiacalix[4]arenes (PAMAM-calix-dendrimers) as nanocarriers for gene therapy.
• To evaluate the ability of PAMAM-calix-dendrimers to complex with small interfering RNAs (siRNAs).
• To assess the safety and efficacy of these novel dendrimers in delivering gene material to cancer cells.

Main Methods:

• Synthesis and characterization of PAMAM-calix-dendrimers.
• Complexation studies with siRNAs.
• In vitro evaluation of siRNA protection against enzymatic degradation.
• Assessment of gene delivery efficiency in HeLa cells.
• Comparative analysis of PAMAM-calix-dendrimers and classical PAMAM dendrimers.

Main Results:

• PAMAM-calix-dendrimers formed stable, positively charged complexes with siRNAs.
• These complexes effectively protected siRNAs from degradation.
• Efficient delivery of gene material to HeLa cells was demonstrated.
• A unique inverse relationship between generation number and cytotoxicity was observed, with no toxicity at effective concentrations.

Conclusions:

• PAMAM-calix-dendrimers are effective and low-toxicity nanocarriers for siRNA delivery.
• These dendrimers offer a promising platform for developing advanced gene delivery systems.
• The findings support the advancement of nanomedicine for cancer therapy.